Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.

Lossos IS, Alizadeh AA, Rajapaksa R, Tibshirani R, Levy R.

Blood. 2003 Jan 15;101(2):433-40.

2.

Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.

Lu X, Nechushtan H, Ding F, Rosado MF, Singal R, Alizadeh AA, Lossos IS.

Blood. 2005 Apr 1;105(7):2924-32. Epub 2004 Dec 9.

3.

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.

Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R, Levy R.

Blood. 2001 Aug 15;98(4):945-51.

4.

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

Chang CC, McClintock S, Cleveland RP, Trzpuc T, Vesole DH, Logan B, Kajdacsy-Balla A, Perkins SL.

Am J Surg Pathol. 2004 Apr;28(4):464-70.

PMID:
15087665
5.

Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas.

Tedoldi S, Paterson JC, Cordell J, Tan SY, Jones M, Manek S, Dei Tos AP, Roberton H, Masir N, Natkunam Y, Pileri SA, Facchetti F, Hansmann ML, Mason DY, Marafioti T.

J Pathol. 2006 Aug;209(4):454-63.

PMID:
16739114
6.

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.

Baecklund E, Natkunam Y, Backlin C, Iliadou A, Askling J, Ekbom A, Feltelius N, Klareskog L, Enblad G, Lossos IS, Levy R, Sundström C, Rosenquist R.

Br J Haematol. 2008 Apr;141(1):69-72. doi: 10.1111/j.1365-2141.2008.07011.x.

PMID:
18324968
7.

Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation.

Natkunam Y, Lossos IS, Taidi B, Zhao S, Lu X, Ding F, Hammer AS, Marafioti T, Byrne GE Jr, Levy S, Warnke RA, Levy R.

Blood. 2005 May 15;105(10):3979-86. Epub 2005 Jan 27.

8.

Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.

Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE, Janda J, Marcu KB, Parwaresch R.

Blood. 2003 May 1;101(9):3574-80. Epub 2003 Jan 2.

9.

Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness.

Schwaller J, Schneider P, Mhawech-Fauceglia P, McKee T, Myit S, Matthes T, Tschopp J, Donze O, Le Gal FA, Huard B.

Blood. 2007 Jan 1;109(1):331-8. Erratum in: Blood. 2007 Sep 1;110(5):1474.

10.

Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.

Sakhinia E, Glennie C, Hoyland JA, Menasce LP, Brady G, Miller C, Radford JA, Byers RJ.

Blood. 2007 May 1;109(9):3922-8. Epub 2007 Jan 25.

11.

High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi Arabia.

Al Kuraya K, Siraj AK, Bavi P, Al-Jomah N, El-Solh H, Ezzat A, Al-Dayel F, Belgaumi A, Al-Kofide A, Sabbah R, Sheikh S, Amr S, Simon R, Sauter G.

Mod Pathol. 2006 Aug;19(8):1124-9. Epub 2006 May 19.

12.

Expression of the serpin centerin defines a germinal center phenotype in B-cell lymphomas.

Paterson MA, Hosking PS, Coughlin PB.

Am J Clin Pathol. 2008 Jul;130(1):117-26. doi: 10.1309/9QKE68QU7B825A3U.

PMID:
18550480
13.

The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.

Barrans SL, Evans PA, O'Connor SJ, Kendall SJ, Owen RG, Haynes AP, Morgan GJ, Jack AS.

Clin Cancer Res. 2003 Jun;9(6):2133-9.

14.

Prognostic significance of metallothionein in B-cell lymphomas.

Poulsen CB, Borup R, Borregaard N, Nielsen FC, Møller MB, Ralfkiaer E.

Blood. 2006 Nov 15;108(10):3514-9. Epub 2006 Jul 25.

15.

High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East.

Al-Kuraya K, Narayanappa R, Siraj AK, Al-Dayel F, Ezzat A, El Solh H, Al-Jommah N, Sauter G, Simon R.

Hum Pathol. 2006 Jun;37(6):742-8.

PMID:
16733216
16.

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.

Berglund M, Thunberg U, Amini RM, Book M, Roos G, Erlanson M, Linderoth J, Dictor M, Jerkeman M, Cavallin-Ståhl E, Sundström C, Rehn-Eriksson S, Backlin C, Hagberg H, Rosenquist R, Enblad G.

Mod Pathol. 2005 Aug;18(8):1113-20.

17.

MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.

Liggins AP, Cooper CD, Lawrie CH, Brown PJ, Collins GP, Hatton CS, Pulford K, Banham AH.

Br J Haematol. 2007 Aug;138(4):479-86. Epub 2007 Jun 29.

PMID:
17608765
18.

Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.

Espinosa I, Briones J, Bordes R, Brunet S, Martino R, Sureda A, Prat J, Sierra J.

Ann Hematol. 2006 Sep;85(9):597-603. Epub 2006 Jul 8.

PMID:
16830142
19.

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.

Iqbal J, Neppalli VT, Wright G, Dave BJ, Horsman DE, Rosenwald A, Lynch J, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Campo E, Ott G, Müller-Hermelink HK, Delabie J, Jaffe ES, Grogan TM, Connors JM, Vose JM, Armitage JO, Staudt LM, Chan WC.

J Clin Oncol. 2006 Feb 20;24(6):961-8. Epub 2006 Jan 17.

PMID:
16418494
20.

Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.

Dupuis J, Gaulard P, Hemery F, Itti E, Gisselbrecht C, Rahmouni A, Copie-Bergman C, Brière J, El Gnaoui T, Gaillard I, Meignan M, Haioun C.

Haematologica. 2007 Jun;92(6):778-83.

Supplemental Content

Support Center